BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30831355)

  • 1. Electrofusion by a bipolar pulsed electric field: Increased cell fusion efficiency for monoclonal antibody production.
    Ke Q; Li C; Wu M; Ge L; Yao C; Yao C; Mi Y
    Bioelectrochemistry; 2019 Jun; 127():171-179. PubMed ID: 30831355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
    Schmitt JJ; Zimmermann U; Neil GA
    Hybridoma; 1989 Feb; 8(1):107-15. PubMed ID: 2925206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell electrofusion using nanosecond electric pulses.
    Rems L; Ušaj M; Kandušer M; Reberšek M; Miklavčič D; Pucihar G
    Sci Rep; 2013 Nov; 3():3382. PubMed ID: 24287643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of bulk cell electrofusion in vitro for production of human-mouse heterohybridoma cells.
    Trontelj K; Rebersek M; Kanduser M; Serbec VC; Sprohar M; Miklavcic D
    Bioelectrochemistry; 2008 Nov; 74(1):124-9. PubMed ID: 18667367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
    Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
    Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On chip electrofusion of single human B cells and mouse myeloma cells for efficient hybridoma generation.
    Kemna EW; Wolbers F; Vermes I; van den Berg A
    Electrophoresis; 2011 Nov; 32(22):3138-46. PubMed ID: 22025094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
    Panova I; Gustafsson B
    Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Bipolar and Unipolar Pulses in Cell Electrofusion: Simulation and Experimental Research.
    Li C; Ke Q; Yao C; Yao C; Mi Y; Wu M; Ge L
    IEEE Trans Biomed Eng; 2019 May; 66(5):1353-1360. PubMed ID: 30281431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of hybridoma secreting anti-mycobacteria monoclonal antibody by using electrofusion technique].
    Guo M; Pan Z; Wang H
    Wei Sheng Wu Xue Bao; 1998 Oct; 38(5):393-5. PubMed ID: 12549406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell electrofusion based on nanosecond/microsecond pulsed electric fields.
    Li C; Ke Q; Yao C; Mi Y; Liu H; Lv Y; Yao C
    PLoS One; 2018; 13(5):e0197167. PubMed ID: 29795594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantially Improved Electrofusion Efficiency of Hybridoma Cells: Based on the Combination of Nanosecond and Microsecond Pulses.
    Wu M; Ke Q; Bi J; Li X; Huang S; Liu Z; Ge L
    Bioengineering (Basel); 2022 Sep; 9(9):. PubMed ID: 36134996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion.
    Schmidt E; Leinfelder U; Gessner P; Zillikens D; Bröcker EB; Zimmermann U
    J Immunol Methods; 2001 Sep; 255(1-2):93-102. PubMed ID: 11470290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced hybridoma production by electrofusion in strongly hypo-osmolar solutions.
    Schmitt JJ; Zimmermann U
    Biochim Biophys Acta; 1989 Jul; 983(1):42-50. PubMed ID: 2758049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of electrofusion parameters for efficient production of murine hybridomas.
    Stenger DA; Kubiniec RT; Purucker WJ; Liang H; Hui SW
    Hybridoma; 1988 Oct; 7(5):505-18. PubMed ID: 3198135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M; Sasamori E; Chiba T; Hanyu Y
    J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines.
    Kandušer M; Ušaj M
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1885-98. PubMed ID: 25010248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrofusion between heterogeneous-sized mammalian cells in a pellet: potential applications in drug delivery and hybridoma formation.
    Li LH; Hensen ML; Zhao YL; Hui SW
    Biophys J; 1996 Jul; 71(1):479-86. PubMed ID: 8804630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electro Cell Fusion for Hybridoma Production.
    Greenfield EA
    Cold Spring Harb Protoc; 2019 Oct; 2019(10):. PubMed ID: 31575798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
    Ohnishi K; Chiba J; Goto Y; Tokunaga T
    J Immunol Methods; 1987 Jun; 100(1-2):181-9. PubMed ID: 3110294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.